Coronavirus (COVID-19) Update: FDA Continues to Combat Fraudulent COVID-19 Medical Products - FDA Press Releases

FDA provides an update on its efforts to combat COVID-19 fraud

from FDA Press Releases RSS Feed https://ift.tt/2zksorS
via IFTTT

Coronavirus (COVID-19) Update: Daily Roundup May 6, 2020 - FDA Press Releases

Coronavirus (COVID-19) Update: Daily Roundup

from FDA Press Releases RSS Feed https://ift.tt/2SY33v9
via IFTTT

FDA Approves First Targeted Therapy to Treat Aggressive Form of Lung Cancer - FDA Press Releases

FDA approves Tabrecta (capmatinib) for the treatment of adult patients with non-small cell lung cancer (NSCLC) that has spread. Tabrecta is the first FDA-approved therapy to treat NSCLC with specific MET exon 14 skipping mutations.

from FDA Press Releases RSS Feed https://ift.tt/2L6DDHc
via IFTTT

Coronavirus (COVID-19) Update: Daily Roundup May 5, 2020 - FDA Press Releases

Coronavirus (COVID-19) Update: Daily Roundup

from FDA Press Releases RSS Feed https://ift.tt/2Wvn6lh
via IFTTT

FDA approves new treatment for a type of heart failure - FDA Press Releases

FDA approves treatment for heart failure with reduced ejection fraction

from FDA Press Releases RSS Feed https://ift.tt/2L0OGla
via IFTTT

Coronavirus (COVID-19) Update: Daily Roundup May 4, 2020 - FDA Press Releases

Coronavirus (COVID-19) Update: Daily Roundup

from FDA Press Releases RSS Feed https://ift.tt/2xycNVa
via IFTTT

Coronavirus (COVID-19) Update: Daily Roundup May 1, 2020 - FDA Press Releases

Coronavirus (COVID-19) Update: Daily Roundup

from FDA Press Releases RSS Feed https://ift.tt/2KTI6gq
via IFTTT

Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment - FDA Press Releases

FDA has issued emergency use authorization for the investigational antiviral drug remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.

from FDA Press Releases RSS Feed https://ift.tt/3disLlN
via IFTTT

Coronavirus (COVID-19) Update: Daily Roundup April 30, 2020 - FDA Press Releases

Coronavirus (COVID-19) Update: Daily Roundup

from FDA Press Releases RSS Feed https://ift.tt/3aTU5Vy
via IFTTT

Coronavirus (COVID-19) Update: FDA Includes Ventilator Developed by NASA in Ventilator Emergency Use Authorization - FDA Press Releases

Coronavirus (COVID-19) Update: FDA Includes Ventilator Developed by NASA in Ventilator Emergency Use Authorization

from FDA Press Releases RSS Feed https://ift.tt/2Yl6eAd
via IFTTT

Coronavirus (COVID-19) Update: Daily Roundup April 29, 2020 - FDA Press Releases

Coronavirus (COVID-19) Update: Daily Roundup

from FDA Press Releases RSS Feed https://ift.tt/35jjAhO
via IFTTT

FDA Grants Marketing of New Device for Continuous Dialysis Therapy for use in Pediatric Patients with Certain Kidney Conditions - FDA Press Releases

FDA grants marketing authorization for a new device indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients weighing between 2.5 and 10 kilograms (or 5.5 to 22 pounds)

from FDA Press Releases RSS Feed https://ift.tt/2yaADXq
via IFTTT

Coronavirus (COVID-19) Update: Daily Roundup April 28, 2020 - FDA Press Releases

Coronavirus (COVID-19) Update: Daily Roundup

from FDA Press Releases RSS Feed https://ift.tt/2VL3gn7
via IFTTT

Coronavirus (COVID-19) Update: Daily Roundup April 27, 2020 - FDA Press Releases

Coronavirus (COVID-19) Update: Daily Roundup

from FDA Press Releases RSS Feed https://ift.tt/2SaDV3S
via IFTTT

FDA Warns Manufacturers and Retailers to Remove Certain E-cigarette Products Targeted to Youth from the Market - FDA Press Releases

FDA issued ten warning letters to retailers and manufacturers who sell, manufacture and/or import unauthorized electronic nicotine delivery system (ENDS) products targeted to youth or likely to promote use by youth.

from FDA Press Releases RSS Feed https://ift.tt/2W0alza
via IFTTT

Coronavirus (COVID-19) Update: FDA Continues to Ensure Availability of Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic, Addresses Safety Concerns - FDA Press Releases

FDA provides an update on its efforts to ensure the availability of alcohol-based sanitizer

from FDA Press Releases RSS Feed https://ift.tt/35bokGA
via IFTTT

Coronavirus (COVID-19) Update: Daily Roundup April 24, 2020 - FDA Press Releases

Coronavirus (COVID-19) Update: Daily Roundup

from FDA Press Releases RSS Feed https://ift.tt/352wocs
via IFTTT

FDA Provides Updates on Adverse Event Reports and Postmarket Activities Associated with Essure - FDA Press Releases

FDA issued a letter to Bayer outlining conditions for submitting additional postmarket information to the agency about Essure. The letter applies to reportable adverse events Bayer is or becomes aware of from social media data received in relation to litigation.

from FDA Press Releases RSS Feed https://ift.tt/2S2Ubng
via IFTTT

Coronavirus (COVID-19) Update: FDA Reiterates Importance of Close Patient Supervision for ‘Off-Label’ Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems - FDA Press Releases

FDA is reiterating the importance of close patient supervision for ‘off-label’ use of antimalarial drugs to mitigate known risks, including heart rhythm problems.

from FDA Press Releases RSS Feed https://ift.tt/2Kx0hbC
via IFTTT

Coronavirus (COVID-19) Update: Daily Roundup April 23, 2020 - FDA Press Releases

Coronavirus (COVID-19) Update: Daily Roundup

from FDA Press Releases RSS Feed https://ift.tt/2XYeIgu
via IFTTT